Cargando…
The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life
PURPOSE: The aim of this study was to examine what personally mattered to 24 patients who received immuno-oncology (IO) therapy for stage IV non-small cell lung cancer (NSCLC), as well as their families and friends, to understand how they evaluated their cancer treatments and the determinants of the...
Autores principales: | Park, Rebekah, Shaw, James W., Korn, Alix, McAuliffe, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256093/ https://www.ncbi.nlm.nih.gov/pubmed/31950409 http://dx.doi.org/10.1007/s11764-020-00853-3 |
Ejemplares similares
-
Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023) -
Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023) -
Framework for life cycle assessment of livestock production systems to account for the nutritional quality of final products
por: McAuliffe, Graham A., et al.
Publicado: (2018) -
Improving Survivors’ Quality of Life Post-Treatment: The Perspectives of Rural Australian Cancer Survivors and Their Carers
por: Gunn, Kate M., et al.
Publicado: (2021) -
Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer
por: Davis, Jennifer S, et al.
Publicado: (2019)